Diabetes
Q&A: AI in diabetes care poses many challenges, benefits to patients and clinicians
AI in diabetes care is becoming more popular with various potential benefits for patients and clinicians as well as important challenges to keep in mind, according to a conversation between two diabetes experts.
VIDEO: Important to not ‘exacerbate’ existing disparities with AI
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about the importance of not worsening disparities with the implementation of AI in diabetes care.
VIDEO: The role of clinicians, stakeholders for AI in diabetes
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about important considerations for using AI in clinical practice.
VIDEO: AI poses potential benefits, challenges in diabetes care
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today co-editor, talks with Edward C. Chao, DO, about the benefits and challenges of using AI in diabetes care.
Bisphenol A tied to decreased insulin sensitivity for healthy adults
ORLANDO — Exposure to bisphenol A may lower insulin sensitivity for healthy adults and may lead to higher risk for type 2 diabetes, according to a speaker at the American Diabetes Association Scientific Sessions.
Higher intake of ultraprocessed foods tied to greater risk for death in older adults
CHICAGO — Middle-aged and older adults who consumed greater amounts of ultraprocessed foods, or UPFs, had an approximately 10% increased risk for death over a median follow-up period of 23 years, according to a study presented at NUTRITION.
These diets could reduce CVD risk for adults with type 1 diabetes
CHICAGO — For adults with type 1 diabetes, the Mediterranean and DASH diets could help reduce the risk for CVD, according to research presented at NUTRITION.
Q&A: Award winner changes career focus after diabetes diagnosis
Shortly after graduating pharmacy school, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, was diagnosed with type 1 diabetes. Learning how to manage the disease while also going through pharmacy training was overwhelming, he said.
Q&A: CGM ‘revolutionary’ for pregnant women with diabetes
Continuous glucose monitors have the potential to alleviate burdens, improve neonatal outcomes and predict disease progression for pregnant women with type 1, type 2 or gestational diabetes, according to two diabetes experts.
VIDEO: CGM is potential tool during pregnancy, postpartum
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about benefits of use of continuous glucose monitoring during and after pregnancy.